(Q28480861)
Statements
High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (English)
0 references
2012
0 references
7
0 references
6
0 references
e39801
0 references
28 June 2012
1 reference
1 reference
1 reference
1 reference
1 reference